Bone Biologics nabs $5.75 mln
Bone Biologics, a Boston-based company developing regenerative medicine for bones, raised $5.75 million in funding from Musculoskeletal Transplant Foundation, OrthoFix Holdings Inc and Hankey Capital LLC. Bone Biologics trades on the OTCQB venture stage marketplace for early stage and developing U.S. and international companies.
1 March 2016•3 mins read
